Literature DB >> 3544257

Immunochemical characterization and purification of Treponema pallidum antigen TpD expressed by Escherichia coli K12.

P Hindersson, A Cockayne, L M Schouls, J D van Emden.   

Abstract

The immunochemical properties of the Treponema pallidum antigen TpD, as expressed by Escherichia coli K12, was investigated by crossed immunoelectrophoresis in which an affinity-purified antibody to this antigen was used. Two immunologically cross-reacting components of TpD with different mobility were demonstrated. Affinity-purified antibodies were used in obtaining purified TpD and in determining the cellular localization of TpD in T. pallidum by immunoelectron microscopy. TpD was localized on the surface of methanol-fixed T. pallidum. Twenty sera from patients with secondary syphilis and 20 sera from nonsyphilitics were examined in crossed immunoelectrophoresis. All sera from patients with secondary syphilis and none from nonsyphilitics contained antibodies to the TpD components. Because TpD seems to be surface associated and a major immunogen during infection with T. pallidum, this antigen might be useful for development of a vaccine against syphilis and for development of improved methods for serodiagnosis of syphilis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3544257     DOI: 10.1097/00007435-198610000-00006

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  12 in total

1.  The 34-kilodalton membrane immunogen of Treponema pallidum is a lipoprotein.

Authors:  M A Swancutt; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

2.  Genome scale identification of Treponema pallidum antigens.

Authors:  Matthew McKevitt; Mary Beth Brinkman; Melanie McLoughlin; Carla Perez; Jerrilyn K Howell; George M Weinstock; Steven J Norris; Timothy Palzkill
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

3.  Identification and localization of integral membrane proteins of virulent Treponema pallidum subsp. pallidum by phase partitioning with the nonionic detergent triton X-114.

Authors:  J D Radolf; N R Chamberlain; A Clausell; M V Norgard
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

4.  Lipid modification of the 17-kilodalton membrane immunogen of Treponema pallidum determines macrophage activation as well as amphiphilicity.

Authors:  D R Akins; B K Purcell; M M Mitra; M V Norgard; J D Radolf
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

5.  Treponema phagedenis encodes and expresses homologs of the Treponema pallidum TmpA and TmpB proteins.

Authors:  D B Yelton; R J Limberger; K Curci; F Malinosky-Rummell; L Slivienski; L M Schouls; J D van Embden; N W Charon
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Reactivity of antibodies from syphilis patients to a protein array representing the Treponema pallidum proteome.

Authors:  Mary Beth Brinkman; Matthew McKevitt; Melanie McLoughlin; Carla Perez; Jerrilyn Howell; George M Weinstock; Steven J Norris; Timothy Palzkill
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

7.  Characterization of the low-molecular-mass proteins of virulent Treponema pallidum.

Authors:  L V Stamm; E A Parrish
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

8.  Isolation and characterization of recombinant Escherichia coli clones secreting a 24-kilodalton antigen of Treponema pallidum.

Authors:  P L Hsu; M Qin; S J Norris; S Sell
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

9.  Treponema pallidum rare outer membrane proteins: analysis of mobility by freeze-fracture electron microscopy.

Authors:  K W Bourell; W Schulz; M V Norgard; J D Radolf
Journal:  J Bacteriol       Date:  1994-03       Impact factor: 3.490

10.  Molecular characterization of the pathogen-specific, 34-kilodalton membrane immunogen of Treponema pallidum.

Authors:  M A Swancutt; B S Riley; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.